These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28664115)

  • 81. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
    Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G
    Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Antiosteoclastogenic activity of silicate-based materials antagonizing receptor activator for nuclear factor kappaB ligand-induced osteoclast differentiation of murine marcophages.
    Hung CJ; Kao CT; Chen YJ; Shie MY; Huang TH
    J Endod; 2013 Dec; 39(12):1557-61. PubMed ID: 24238446
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pine needles attenuate receptor activator for nuclear factor-B ligand (RANKL)-induced trabecular bone loss by inhibiting osteoclast differentiation.
    Shim KS; Ma JY
    Integr Med Res; 2018 Dec; 7(4):374-380. PubMed ID: 30591892
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Water Extract of
    Jang SA; Hwang YH; Kim T; Yang H; Lee J; Seo YH; Park JI; Ha H
    Foods; 2020 Aug; 9(9):. PubMed ID: 32858922
    [TBL] [Abstract][Full Text] [Related]  

  • 85. α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption.
    Kim HN; Lee JH; Jin WJ; Lee ZH
    J Bone Metab; 2012 Nov; 19(2):111-20. PubMed ID: 24524041
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption.
    Lim S; Ihn HJ; Kim JA; Bae JS; Kim JE; Bae YC; Shin HI; Kim TH; Park EK
    Anim Cells Syst (Seoul); 2023; 27(1):1-9. PubMed ID: 36704446
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of veraguensin and galgravin on osteoclast differentiation and function.
    Asai M; Lee JW; Itakura Y; Choi BK; Yonezawa T; Teruya T; Cha BY; Ohnishi M; Yamaguchi A; Woo JT
    Cytotechnology; 2012 May; 64(3):315-22. PubMed ID: 22526488
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Water Extract of
    Jang SA; Hwang YH; Yang H; Ryuk JA; Kim T; Ha H
    Front Pharmacol; 2021; 12():719602. PubMed ID: 34421614
    [No Abstract]   [Full Text] [Related]  

  • 89. Cepharanthine suppresses osteoclast formation by modulating the nuclear factor-κB and nuclear factor of activated T-cell signaling pathways.
    Lin X; Song F; Zhou L; Wang Z; Wei C; Xu J; Zhao J; Liu Q
    J Cell Biochem; 2019 Feb; 120(2):1990-1996. PubMed ID: 30426543
    [TBL] [Abstract][Full Text] [Related]  

  • 90.
    Jeong DW; Kim EY; Kim JH; Lee B; Hong S; Park JH; Jung HS; Sohn Y
    Evid Based Complement Alternat Med; 2019; 2019():3231784. PubMed ID: 30915145
    [No Abstract]   [Full Text] [Related]  

  • 91. Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation
    Kang N; Kim KW; Shin DM
    Korean J Physiol Pharmacol; 2019 Sep; 23(5):411-417. PubMed ID: 31496878
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Extracts of
    Kim KJ; Lee Y; Jeong MH; Hur JS; Son YJ
    J Bone Metab; 2019 May; 26(2):113-121. PubMed ID: 31223608
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1.
    Ihn HJ; Lee T; Lee D; Bae JS; Kim SH; Jang IH; Bae YC; Shin HI; Park EK
    Front Pharmacol; 2019; 10():367. PubMed ID: 31024321
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Extracellular Vesicles Derived From Murine Cementoblasts Possess the Potential to Increase Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastogenesis.
    Sato R; Maruyama K; Nemoto E; Sakisaka Y; Suzuki S; Li J; Numazaki K; Tada H; Yamada S
    Front Physiol; 2022; 13():825596. PubMed ID: 35237179
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Adrenomedullin inhibits osteoclast differentiation through the suppression of receptor activator of nuclear factor-κB ligand-induced nuclear factor-κB activation in glucocorticoid-induced osteoporosis.
    Liu Y; Zuo G; Meng X; Gao X; Zhang L; Tang P
    Exp Ther Med; 2017 Nov; 14(5):4009-4016. PubMed ID: 29067096
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition.
    Hwang YH; Lee A; Kim T; Jang SA; Ha H
    Plants (Basel); 2021 May; 10(5):. PubMed ID: 34068461
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Purification and Biological Function of Caldecrin.
    Tomomura A; Bandow K; Tomomura M
    Medicines (Basel); 2021 Jul; 8(8):. PubMed ID: 34436220
    [TBL] [Abstract][Full Text] [Related]  

  • 98. 10-Gingerol Suppresses Osteoclastogenesis in RAW264.7 Cells and Zebrafish Osteoporotic Scales.
    Zang L; Kagotani K; Nakayama H; Bhagat J; Fujimoto Y; Hayashi A; Sono R; Katsuzaki H; Nishimura N; Shimada Y
    Front Cell Dev Biol; 2021; 9():588093. PubMed ID: 33748100
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Caldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and function.
    Tomomura M; Tomomura A
    World J Biol Chem; 2015 Nov; 6(4):358-65. PubMed ID: 26629319
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of the Lysine Methyltransferase Inhibitor AZ505 on Bone Metabolism.
    Song MK; Jung S; Hong S; Kwon JO; Kim MK; Kim HH
    J Bone Metab; 2021 Nov; 28(4):297-305. PubMed ID: 34905676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.